27 Sep FDA Approves First Novel Drug for Schizophrenia in Decades
Xanomeline and trospium chloride (Cobenfy) has no boxed warnings...
Xanomeline and trospium chloride (Cobenfy) has no boxed warnings...
She is the first person with type 1 diabetes to receive this kind of transplant....
The clinical research industry is increasingly recognizing the need for diversity, especially as it relates to the Latino population and other minorities. ...
University of Wisconsin health officials were pleased when the leadership of one tribal community in northern Wisconsin recently agreed to meet about the possibility of signing up tribal members for clinical health trials....
Wisconsin has become an emerging hub for studying and developing theranostics, an approach to treating cancer, according to local researchers....
In recognition of September being World Alzheimer’s Month, ACRP sought out commentary on a type of therapy for the disease that’s not as well known to the public as the recently approved pharmaceuticals....
Several questions have recently arisen regarding the use of the Care Everywhere platform for research purposes at UW–Madison and UW Health....
Tribal council’s historic visit strengthens relationship with UW’s health researchers...
A gene variant called APOE4 is notorious for its link to Alzheimer’s. Can new insights into its function help stave off disease?...
A conversation with Sally Lau, MD, thoracic medical oncologist, Perlmutter Cancer Center, NYU Langone Health...